Key result
An invasive strategy decreased 1-year mortality compared to a conservative strategy in patients with non-ST-elevation acute coronary syndromes (RR 0.276; 95% CI 0.259-0.294).
Why the study?
Does an invasive strategy reduce all-cause mortality at 30 days and 1 year in patients with non-ST-elevation acute coronary syndromes compared to a conservative strategy?
Meta-Analysis
Does an invasive strategy reduce all-cause mortality at 30 days and 1 year in patients with non-ST-elevation acute coronary syndromes compared to a conservative strategy?
This meta-analysis of 7 studies suggests an invasive strategy significantly reduces 1-year mortality in patients with NSTE-ACS compared to a conservative strategy.
Supports invasive strategy to cut 1-year mortality in NSTE-ACS; confirms benefit across 7 studies.
OBJECTIVE: The goal of the present study was to compare the prognoses of patients with non-ST-elevation acute coronary syndromes who were treated with invasive or conservative treatment strategies. METHODS: We performed a meta-analysis of studies of patients with non-ST-elevation acute coronary syndromes to assess the benefits of an invasive strategy vs. a conservative strategy for short- and long-term survival. We searched PubMed for studies published from 1990 to November 2012 that investigated the effects of an invasive vs. conservative strategy in patients with non-ST-elevation acute coronary syndromes. The following search terms were used: "non-ST-elevation myocardial infarction", "unstable angina", "acute coronary syndromes", "invasive strategy", and "conservative strategy". The primary endpoints were all-cause mortality at 30 days and 1 year. RESULTS: Seven published studies were included in the present meta-analysis. The pooled analyses show that an invasive strategy decreased the risk of death (risk ratio [0.839] [95% confidence interval {0.648-1.086}; I 2, 86.46%] compared to a conservative strategy over a 30-day-period. Furthermore, invasive treatment also decreased patient mortality (risk ratio [0.276] [95% confidence interval {0.259-0.294}; I 2, 94.58%]) compared to a conservative strategy for one year. CONCLUSION: In non-ST-elevation acute coronary syndromes, an invasive strategy is comparable to a conservative strategy for decreasing short- and long-term mortality rates.
No takes yet. Share an insight, caveat, or question.
Li et al. (2014) conducted a meta-analysis in Non-ST-elevation acute coronary syndromes. Invasive strategy vs. Conservative strategy was evaluated on All-cause mortality at 30 days and 1 year (RR 0.276, 95% CI 0.259-0.294). An invasive strategy decreased 1-year mortality compared to a conservative strategy in patients with non-ST-elevation acute coronary syndromes (RR 0.276; 95% CI 0.259-0.294).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: